Please Note: This event has already taken place.
Patent-Eligible Subject Matter in the US-- Genes and Diagnostics: A Myriad of Issues in Biotech IP
Thursday, November 7, 2013
12:00 PM to 1:00 PM
Boston Bar Association - 16 Beacon Street, Boston, MA
Laura A. Coruzzi
(Jones Day, New York), a member of the Jones Day team that twice argued the
Association for Molecular Pathology v. Myriad Genetics case at the Court of
Appeals for the Federal Circuit and at the U.S. Supreme Court, will discuss
recent Supreme Court decisions under Section 101, along with what the Mayo
Collaborative Services v. Prometheus Laboratories, Inc. and Myriad
patent-eligibility standards mean for the future of patent law in the field of
personalized medicine. A historical perspective on how and why the current
criteria for patent eligibility evolved and the potential for legislative change
will be provided.
BBA Event Calendar